Global active pharmaceutical ingredients (API) market will reach $ 386.2 billion by 2032, growing by 6.4% annually over 2022-2032, driven by rising adoption of biologics in disease management, increasing regulatory approvals, patent expiration of major drugs, growing trend of outsourcing and increase in geriatric population.
Highlighted with 141 tables and 111 figures, this 258-page report "Global Active Pharmaceutical Ingredients (API) Market 2022-2032 by Molecule (Small, Large), Synthesis (Synthetic, Biotech, HPAPI), Manufacturing Process (Captive, Merchant), Therapeutic Application, Drug Type, and Region: Trend Forecast and Growth Opportunity" is based on a comprehensive research of the entire global active pharmaceutical ingredients (API) market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2020-2022 and provides forecast from 2023 till 2032 with 2022 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter's Fiver Forces
The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify global active pharmaceutical ingredients (API) market in every aspect of the classification from perspectives of Molecule, Synthesis, Manufacturing Process, Therapeutic Application, Drug Type, and Region.
Based on Molecule, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
• Small Molecule APIs
• Large Molecule APIs
Based on Synthesis, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
• Synthetic API
o Branded Synthetic API
o Generic Synthetic API
• Biotech API
o by type
Monoclonal Antibodies
Recombinant Proteins
Vaccines
Other Biotech APIs
o by Category
Innovative Biologic API
Generic Biosimilar API
o by Expression
Mammalian Expression
Microbial Expression
Yeast Expression
Insect Expression
Other Expression Technologies
• HPAPI
o Branded HPAPI
o Generic HPAPI
Based on Manufacturing Process, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
• Captive Manufacturing
o Branded Captive API
o Generic Captive API
• Merchant Manufacturing
o by Drug Type
Branded Merchant API
Generic Merchant API
o by Drug Synthesis
Merchant Synthetic API
Merchant Biotech API
By Therapeutic Application, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
• Infectious Diseases
• Oncology
• Ophthalmology
• Cardiovascular Disorders
• Central Nervous System
• Pulmonary Disorders
• Orthopedics
• Other Applications
By Drug Type, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
• Branded Prescription Drugs
• Generic Prescription Drugs
• OTC Drugs
Geographically, the following regions together with the listed national/local markets are fully investigated:
• North America (U.S., Canada, and Mexico)
• Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
• APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
• South America (Brazil, Chile, Argentina, Rest of South America)
• MEA (UAE, Saudi Arabia, South Africa and Rest of MEA)
For each aforementioned region and country, detailed analysis and data for annual revenue ($ mn) are available for 2022-2032. The breakdown of all regional markets by country and split of each national market by Synthesis, Manufacturing Process, and Therapeutic Application over the forecast years are also included.
The report also covers the current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
AbbVie Inc.
Astrazeneca
Aurobindo Pharma Ltd.
BASF
Bayer AG
Boehringer Ingelheim
Catalent Inc.
Dr. Reddy's Laboratories
F. Hoffmann-La Roche
GlaxoSmithKline plc
Lonza Group
Lupin Limited
Merck & Co., Inc.
Mylan NV
Novartis International AG
Pfizer Inc.
Sanofi
Sun Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd.
Thermo Fisher Scientific
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
1 Introduction 13
1.1 Industry Definition and Research Scope 13
1.1.1 Industry Definition 13
1.1.2 Research Scope 14
1.2 Research Methodology 17
1.2.1 Overview of Market Research Methodology 17
1.2.2 Market Assumption 18
1.2.3 Secondary Data 18
1.2.4 Primary Data 18
1.2.5 Data Filtration and Model Design 19
1.2.6 Market Size/Share Estimation 20
1.2.7 Research Limitations 21
1.3 Executive Summary 22
2 Market Overview and Dynamics 25
2.1 Market Size and Forecast 25
2.1.1 Impact of COVID-19 on World Economy 26
2.1.2 Impact of COVID-19 on the Market 29
2.1.3 Impact of Russia-Ukraine Conflict: War Slows Economic Recovery 36
2.2 Major Growth Drivers 40
2.3 Market Restraints and Challenges 48
2.4 Emerging Opportunities and Market Trends 51
2.5 Porter's Fiver Forces Analysis 55
3 Segmentation of Global Market by Molecule 59
3.1 Market Overview by Molecule 59
3.2 Small Molecule APIs 61
3.3 Large Molecule APIs 62
4 Segmentation of Global Market by Synthesis 63
4.1 Market Overview by Synthesis 63
4.2 Synthetic API 65
4.2.1 Branded Synthetic API 66
4.2.2 Generic Synthetic API 67
4.3 Biotech API 68
4.3.1 Biotech API by Drug Type 69
4.3.1.1 Monoclonal Antibodies 70
4.3.1.2 Recombinant Proteins 71
4.3.1.3 Vaccines 72
4.3.1.4 Other Biotech APIs 73
4.3.2 Biotech API by Category 74
4.3.2.1 Innovative Biologic API 75
4.3.2.2 Generic Biosimilar API 76
4.3.3 Biotech API by Expression Technology 77
4.3.3.1 Mammalian Expression 78
4.3.3.2 Microbial Expression 79
4.3.3.3 Yeast Expression 80
4.3.3.4 Insect Expression 81
4.3.3.5 Other Expression Technologies 82
4.4 HPAPI 83
4.4.1 Branded HPAPI 84
4.4.2 Generic HPAPI 85
5 Segmentation of Global Market by Manufacturing Process 86
5.1 Market Overview by Manufacturing Process 86
5.2 Captive Manufacturing 88
5.2.1 Branded Captive API 89
5.2.2 Generic Captive API 90
5.3 Merchant Manufacturing 91
5.3.1 Merchant Manufacturing by Drug Type 92
5.3.1.1 Branded Merchant API 93
5.3.1.2 Generic Merchant API 94
5.3.2 Merchant Manufacturing by Drug Synthesis 95
5.3.2.1 Merchant Synthetic API 96
5.3.2.2 Merchant Biotech API 97
6 Segmentation of Global Market by Therapeutic Application 98
6.1 Market Overview by Therapeutic Application 98
6.2 Infectious Diseases 100
6.3 Oncology 101
6.4 Ophthalmology 102
6.5 Cardiovascular Disorders 103
6.6 Central Nervous System 104
6.7 Pulmonary Disorders 105
6.8 Orthopedics 106
6.9 Other Applications 107
7 Segmentation of Global Market by Drug Type 108
7.1 Market Overview by Drug Type 108
7.2 Branded Prescription Drugs 110
7.3 Generic Prescription Drugs 111
7.4 OTC Drugs 112
8 Segmentation of Global Market by Region 113
8.1 Geographic Market Overview 2022-2032 113
8.2 North America Market 2022-2032 by Country 117
8.2.1 Overview of North America Market 117
8.2.2 U.S. 120
8.2.3 Canada 130
8.2.4 Mexico 132
8.3 European Market 2022-2032 by Country 134
8.3.1 Overview of European Market 134
8.3.2 UK 137
8.3.3 France 139
8.3.4 Germany 141
8.3.5 Spain 143
8.3.6 Italy 145
8.3.7 Russia 147
8.3.8 Rest of European Market 149
8.4 Asia-Pacific Market 2022-2032 by Country 151
8.4.1 Overview of Asia-Pacific Market 151
8.4.2 China 154
8.4.3 Japan 156
8.4.4 India 159
8.4.5 Australia 161
8.4.6 South Korea 163
8.4.7 Rest of APAC Region 165
8.5 South America Market 2022-2032 by Country 167
8.5.1 Argentina 170
8.5.2 Brazil 172
8.5.3 Chile 174
8.5.4 Rest of South America Market 176
8.6 MEA Market 2022-2032 by Country 177
8.6.1 UAE 180
8.6.2 Saudi Arabia 182
8.6.3 South Africa 184
8.6.4 Other National Markets 186
9 Competitive Landscape 187
9.1 Overview of Key Vendors 187
9.2 New Product Launch, Partnership, Investment, and M&A 190
9.3 Company Profiles 191
AbbVie Inc. 191
Astrazeneca 193
Aurobindo Pharma Ltd. 198
BASF 201
Bayer AG 204
Boehringer Ingelheim 208
Catalent Inc. 213
Dr. Reddy's Laboratories 216
F. Hoffmann-La Roche 218
GlaxoSmithKline plc 221
Lonza Group 226
Lupin Limited 230
Merck & Co., Inc. 233
Mylan NV 236
Novartis International AG 239
Pfizer Inc. 242
Sanofi 247
Sun Pharmaceutical Industries Ltd. 250
Teva Pharmaceutical Industries Ltd. 253
Thermo Fisher Scientific 255
Related Reports and Products 258
The Freeze-drying Pharmaceutical Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufa...
The Active RFID Asset Management Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufa...
Market Overview
The Asia Pacific Vascular Closure Devices Market is anticipated to experience substantial growth from 2024 to 2034. The market's expansion is fueled by advancements in vascular closure technologies, increasing prevalence of cardiovascular diseases, and the growing adopti...
Market Overview
The Europe Vascular Closure Devices Market is poised for significant growth from 2024 to 2034, driven by advancements in minimally invasive procedures, increasing procedural volumes, and a growing preference for vascular closure solutions that enhance patient outcomes. T...
Market Overview
The North America Vascular Closure Devices (VCD) Market is anticipated to witness significant growth from 2024 to 2034, driven by the increasing volume of minimally invasive cardiovascular procedures, rising prevalence of cardiovascular diseases, and advancements in vasc...
Market Overview
The Global Vascular Closure Devices Market is projected to grow substantially from 2024 to 2034, driven by the increasing volume of minimally invasive cardiovascular procedures and the rising demand for fast, efficient vascular closure solutions. In 2024, the market is v...
The Pharmaceutical Cost Management Platforms Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive lands...
The Pharmaceutical Purified Water Solution Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landsca...
The Pharmaceutical Intellectual Property Protection Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitiv...
The Pharmaceutical Safety Assessment Services Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive land...